Decreased Aryl Hydrocarbon Receptor Gene Expression and Polymorphic Variants Association with Increase COPD Risk.

Area of Science:

• Genetics
• Pulmonology
• Molecular Biology

Background:

• The Aryl Hydrocarbon Receptor (AHR) is a transcription factor involved in xenobiotic metabolism.
• The role of AHR in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis is not well understood.
• Investigating AHR gene polymorphisms and expression in COPD is crucial for understanding disease mechanisms.

Purpose of the Study:

• To examine the association between AHR gene polymorphisms (rs2066853 and rs2074113) and COPD.
• To compare AHR gene expression levels in COPD patients versus healthy individuals.
• To determine if AHR polymorphisms correlate with AHR gene expression in COPD.

Main Methods:

• Genotyping of AHR polymorphisms rs2066853 and rs2074113 using Amplification Refractory Mutation System-Polymerase Chain Reaction (ARMS-PCR).
• Quantification of AHR gene expression via Reverse Transcription Polymerase Chain Reaction (RT-PCR).
• Comparative analysis of genotype frequencies and gene expression between 154 COPD patients and 145 healthy controls.

Main Results:

• Significant differences in AHR rs2066853 genotype frequencies (GG, GA) and allele frequencies (G, A) between COPD patients and controls.
• A significant association was found between the GT genotype of AHR rs2074113 and COPD.
• COPD patients exhibited significantly lower AHR gene expression compared to healthy controls, with the GA genotype showing reduced expression.

Conclusions:

• The AHR rs2066853 polymorphism, particularly allele A and the GA genotype, is associated with an increased genetic predisposition to COPD.
• Reduced AHR gene expression in COPD patients highlights its potential role in the disease's development and progression.
• These findings suggest AHR as a potential therapeutic target for COPD.